How geometric structure affects oxygen use in chemical reactions involving iron complexes
The role of geometric structure in avoidance of oxygen rebound to enable aliphatic halogenation and oxacyclization by non-heme Fe(IV)-oxo (ferryl) complexes
This study is looking at how the shape of certain iron compounds can help make important chemical reactions better, which is really useful for creating new medicines, and it’s for anyone interested in making drug production more efficient and eco-friendly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-11098841 on NIH RePORTER |
What this research studies
This research investigates how the geometric structure of iron complexes influences their ability to catalyze important chemical reactions, such as hydroxylation and halogenation, which are crucial for drug synthesis. By studying specific enzymes that depend on iron and 2-oxoglutarate, the research aims to understand how these enzymes can be optimized for more efficient and environmentally friendly drug production. The approach involves detailed spectroscopic analysis to observe how these enzymes adjust their structures during reactions, providing insights that could enhance their application in the pharmaceutical industry.
Who could benefit from this research
Good fit: Patients who may benefit from this research are those requiring new or improved medications derived from natural products.
Not a fit: Patients who are not seeking new treatments or those with conditions that do not rely on drug synthesis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and sustainable methods for producing vital medications.
How similar studies have performed: Previous research has shown promise in using similar enzymatic approaches for drug synthesis, indicating potential for success in this area.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Silakov, Alexey — Pennsylvania State University, the
- Study coordinator: Silakov, Alexey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.